KLP Kapitalforvaltning’s Amphastar Pharmaceuticals AMPH Stock Holding History

KLP Kapitalforvaltning’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155K	Hold	7,900	–	–	﹤0.01%	1914
2025 Q4	$212K	Buy	7,900 +500	+7%	+$12.9K	﹤0.01%	1817
2025 Q3	$197K	Hold	7,400	–	–	﹤0.01%	1833
2025 Q2	$170K	Hold	7,400	–	–	﹤0.01%	1846
2025 Q1	$215K	Hold	7,400	–	–	﹤0.01%	1722
2024 Q4	$275K	Buy	+7,400	New	+$338K	﹤0.01%	1691

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

KLP Kapitalforvaltning's AMPH Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Amphastar Pharmaceuticals (AMPH) position steady in Q1 2026 at 7,900 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

KLP Kapitalforvaltning first reported a position in AMPH in Q4 2024 and has held it in 6 quarters since. The position peaked at $275K in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

KLP Kapitalforvaltning held 7,900 shares of Amphastar Pharmaceuticals worth $155K as of Q1 2026.
KLP Kapitalforvaltning left its Amphastar Pharmaceuticals share count unchanged in Q1 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1914 holding.
KLP Kapitalforvaltning first reported a position in Amphastar Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
KLP Kapitalforvaltning's Amphastar Pharmaceuticals position peaked at $275K in Q4 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.